Management of Elderly Patients with Chronic Hyponatremia, Hypokalemia, and Hypoglycemia

Immediate Assessment and Stabilization

The American Diabetes Association recommends administering 15-20g of simple carbohydrates immediately if the patient is conscious and able to swallow, or intravenous dextrose if altered mental status is present 1, 2
The American Diabetes Association advises never to discontinue basal insulin if the patient has type 1 diabetes, even with poor oral intake, as this precipitates diabetic ketoacidosis 3, 2
The American Diabetes Association suggests targeting a glucose range of 140-180 mg/dL in elderly patients to balance glycemic control against hypoglycemia risk, which carries a 1.81-fold increased mortality risk for moderate hypoglycemia and 3.21-fold for severe hypoglycemia 4, 2
The American Diabetes Association recommends avoiding sliding-scale insulin alone as this approach is associated with poor outcomes and higher hypoglycemia rates in elderly patients 5, 3

The American Diabetes Association recommends assessing for malnutrition risk factors, including finances, grocery shopping ability, meal preparation capacity, changes in taste/smell, dentition problems, swallowing difficulties, and cognitive impairment 1, 6
The American Diabetes Association suggests evaluating protein-energy status as elderly patients with diabetes are at increased risk of sarcopenia and cachexia, requiring protein intake of 1.2-1.5 g/kg/day with acute or chronic diseases 1, 7
The American Diabetes Association advises avoiding restrictive diets in patients aged >70 years or in states of undernutrition, as these increase the risk of sarcopenia and malnutrition 1, 6

The American Diabetes Association recommends relaxing A1C targets to 8-8.5% in elderly patients with shortened life expectancies, significant comorbidities, or history of severe hypoglycemia to reduce mortality risk 8, 5
The American Diabetes Association suggests balancing the stringency of glycemic targets against hypoglycemia risk, which is especially dangerous in elderly patients with renal failure, malnutrition, malignancies, dementia, and frailty 1, 4
The American Diabetes Association advises considering basal insulin regimens alone rather than basal-bolus or premixed regimens to decrease hypoglycemia risk, as oral agents may achieve similar glycemic outcomes in long-term care populations 6, 5

The American Diabetes Association recommends checking renal function (creatinine, GFR) as elderly patients with renal insufficiency have decreased gluconeogenesis, impaired insulin clearance, and blunted counterregulatory responses predisposing to hypoglycemia 4
The American Diabetes Association suggests assessing albumin levels as low albumin is a predictive marker of hypoglycemia in elderly hospitalized patients 4
The American Diabetes Association advises evaluating mental status frequently as elderly patients fail to perceive neuroglycopenic and autonomic hypoglycemic symptoms, delaying recognition and treatment 4

The American Diabetes Association recommends not targeting tight glycemic control (A1C <7%) in elderly patients with multiple comorbidities, as this increases hypoglycemia risk without mortality benefit 4, 8, 5
The American Diabetes Association advises not using premixed insulin formulations in elderly patients, as they have threefold higher hypoglycemia rates compared to basal-bolus regimens 3